Alzheimer's disease & dementia

Alzheimer's disease is a 'double-prion disorder,' study shows

Two proteins central to the pathology of Alzheimer's disease act as prions—misshapen proteins that spread through tissue like an infection by forcing normal proteins to adopt the same misfolded shape—according to new ...

Alzheimer's disease & dementia

Scientists propose new theory on Alzheimer's, amyloid connection

Worldwide, 50 million people are living with Alzheimer's disease and other dementias. According to the Alzheimer's Association, every 65 seconds someone in the United States develops this disease, which causes problems with ...

Medical research

A possible blood test for early-stage Alzheimer's disease

A large team of researchers affiliated with a host of institutions across South Korea has developed a possible blood test to detect the early stages of Alzheimer's disease in patients who have yet to exhibit symptoms. In ...

Alzheimer's disease & dementia

Alzheimer's diagnosis, management improved by brain scans

A first-of-its-kind national study has found that a form of brain imaging that detects Alzheimer's-related "plaques" significantly influenced clinical management of patients with mild cognitive impairment and dementia.

Alzheimer's disease & dementia

'Lack of cleaning' in brain cells is central to Alzheimer's disease

An international research team with representation from the University of Copenhagen has created a better understanding of Alzheimer's. They have shown that the cleaning system of the brain cells, a process called mitophagy, ...

Alzheimer's disease & dementia

A new culprit of cognitive decline in Alzheimer's disease

It has long been known that patients with Alzheimer's disease have abnormalities in the vast network of blood vessels in the brain. Some of these alterations may also contribute to age-related cognitive decline in people ...

Alzheimer's disease & dementia

New compound shows promise in treatment of Alzheimer's

Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer's and even restores memories in mice, they report Jan. 2 in the journal Cell Reports.

page 24 from 40